Founded in 2013, Kleinmuntz Associates is a closely-held venture capital firm based in Chicago. Our emphasis is on analytics and biotechnology focused on cancer care. We work with very early stage startup companies using an approach that combines angel capital investment with business advisory services.
WHO WE ARE
Empowering Precision Cancer Care
Simbiosys is a technology company on a mission to deploy Computational Oncology to transform decision making and patient experience in Cancer Care. By virtualizing cancer, clinicians and patients are empowered with a better understanding of the disease and can assess all available options to truly individualize treatment. The company was founded in 2018 at the University of Illinois at Urbana-Champaign.